Loading…
Loading…
CHX (ChampionX Corporation) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CHX and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CHX and 80,000+ other tickers.
See exactly how CHX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CHX and 80,000+ other tickers.
ChampionX Corporation is a global leader specializing in advanced chemistry solutions, engineered equipment, and innovative technologies for the oil and gas industry. The company's operations are divided into several key segments: Production Chemical Technologies: This division supplies a comprehensive range of chemical treatments for both onshore and offshore operations. These solutions, including corrosion and scale inhibitors, emulsion breakers, and biocides, are vital for upstream and midstream oil and gas sectors. They effectively address critical challenges like managing corrosion…
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against ChampionX Corporation ("ChampionX" or the "Company") (NASDAQ: CHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
LOS ANGELES, July 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ChampionX Corporation, (“ChampionX” or the "Company") (NASDAQ: CHX) investors of a class action on behalf of investors that bought securities between February 29, 2024 and April 1, 2024, inclusive (the “Class Period”). CHX investors have until July 14, 2026 to file a lead plaintiff motion.
NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of ChampionX Corporation (NASDAQ: CHX) between February 29, 2024 and April 1, 2024, inclusive (the “Class Period”), of the important July 14, 2026 lead plaintiff deadline.
If you sold common stock of ChampionX between February 29, 2024 and April 1, 2024 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.